Discovery of new VEGFR-2 inhibitors and apoptosis inducer-based thieno[2,3-d]pyrimidine

被引：12

作者：

El-Metwally, Souad A. ^{[1
]}

Elkady, Hazem ^{[2
]}

Hagras, Mohamed ^{[3
]}

Elkaeed, Eslam B. ^{[4
]}

Alsfouk, Bshra A. ^{[5
]}

Doghish, Ahmed S. ^{[6
,7
]}

Ibrahim, Ibrahim M. ^{[8
]}

Taghour, Mohammed S. ^{[2
]}

Husein, Dalal Z. ^{[9
]}

Metwaly, Ahmed M. ^{[10
,11
]}

Eissa, Ibrahim H. ^{[1
]}

机构：

[1] Higher Technol Inst, Dept Basic Sci, 10th Ramadan City, Egypt

[2] Al Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, Egypt

[3] Al Azhar Univ, Coll Pharm, Dept Pharmaceut Organ Chem, Cairo 11884, Egypt

[4] AlMaarefa Univ, Coll Pharm, Dept Pharmaceut Sci, Riyadh 13713, Saudi Arabia

[5] Princess Nourah bint Abdulrahman Univ, Coll Pharm, Dept Pharmaceut Sci, POB 84428, Riyadh 11671, Saudi Arabia

[6] Badr Univ Cairo BUC, Fac Pharm, Dept Biochem, Cairo 11829, Egypt

[7] Al Azhar Univ, Fac Pharm Boys, Biochem & Mol Biol Dept, Cairo 11231, Egypt

[8] Cairo Univ, Fac Sci, Biophys Dept, Cairo 12613, Egypt

[9] New Valley Univ, Fac Sci, Chem Dept, El Kharja 72511, Egypt

[10] Al Azhar Univ, Fac Pharm Boys, Pharmacognosy & Med Plants Dept, Cairo 11884, Egypt

[11] Genet Engn & Biotechnol Res Inst, Biopharmaceut Prod Res Dept, City Sci Res & Technol Applicat SRTA City, Alexandria, Egypt

来源：

FUTURE MEDICINAL CHEMISTRY | 2023年 / 15卷 / 22期

关键词：

apoptosis; docking; MD simulations; thieno[2,3-d]pyrimidine; VEGFR-2; IN-SILICO; MOLECULAR DOCKING; CELL-LINES; DESIGN; DERIVATIVES; TOXICITY; ADMET; ANTICANCER; VITRO; ANGIOGENESIS;

D O I：

10.4155/fmc-2023-0130

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Background: VEGFR-2 is a key regulator of cancer cell proliferation, migration and angiogenesis. Aim: Development of thieno[2,3-d]pyrimidine derivatives as potential anti-cancer agents targeting VEGFR-2. Methods: Seven in vitro and nine in silico studies were conducted. Results: Compound 10d demonstrated strong anticancer potential, boosting apoptosis based on VEGFR-2 inhibition. It arrested the S phase of the cell cycle and upregulated the apoptotic factors. Docking and molecular dynamics simulation studies confirm the stability of the VEGFR-2-10d complex and suggest that these compounds have good binding affinities to VEGFR-2. In addition, the drug-likeness was confirmed. Conclusion: Thieno[2,3-d]pyrimidines, particularly compound 10d, has good anticancer effects and may contribute to the development of new anticancer therapies.

引用

页码：2065 / 2086

页数：22

共 50 条

[21] Discovery of new thieno[2,3-d]pyrimidine and thiazolo[5,4-d]pyrimidine derivatives as orally active phosphoinositide 3-kinase inhibitors
Sun, Yan
Fu, Rong
Lin, Songwen
Zhang, Jingbo
Ji, Ming
Zhang, Yan
Wu, Deyu
Zhang, Kehui
Tian, Hua
Zhang, Mingyi
Sheng, Li
Li, Yan
Jin, Jing
Chen, Xiaoguang
Xu, Heng
BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 29
[22] SYNTHESIS OF NOVEL THIENO[2,3-D]PYRIMIDINE, THIENO[2,3-B]PYRIDINE AND THIAZOLO[3,2-A]THIENO[2,3-D]PYRIMIDINE DERIVATIVES AND THEIR EFFECT ON THE PRODUCTION OF MYCOTOXINS
ABDELRAZEK, FM
SALAH, AM
ELBAZZA, ZE
ARCHIV DER PHARMAZIE, 1992, 325 (05) : 301 - 305
[23] Discovery of new thieno[2,3-d]pyrimidines as EGFR tyrosine kinase inhibitors for cancer treatment
Sobh, Eman A.
Dahab, Mohammed A.
Elkaeed, Eslam B.
Alsfouk, Aisha A.
Ibrahim, Ibrahim M.
Metwaly, Ahmed M.
Eissa, Ibrahim H.
FUTURE MEDICINAL CHEMISTRY, 2023, 15 (13) : 1167 - 1184
[24] Anti-breast cancer potential of thieno-pyrimidine derivatives as VEGFR-2 inhibitors
Alsfouk, Aisha A.
Al Ward, Maged Mohammed Saleh
Al-Qadhi, Mustafa A.
El-Metwally, Souad A.
Yousef, Reda G.
Elkaeed, Eslam B.
Husein, Dalal Z.
Amin, Fatma G.
Elkady, Hazem
Metwaly, Ahmed M.
Eissa, Ibrahim H.
FUTURE MEDICINAL CHEMISTRY, 2025,
[25] Discovery of New Pyrrolo[2,3-d]pyrimidine Derivatives as Potential Multi-Targeted Kinase Inhibitors and Apoptosis Inducers
Alotaibi, AbdulAziz A.
Alanazi, Mohammed M.
Rahman, A. F. M. Motiur
PHARMACEUTICALS, 2023, 16 (09)
[26] Discovery and optimization of thieno[2,3-d]pyrimidines as B-Raf inhibitors
Packard, Garrick K.
Papa, Patrick
Riggs, Jennifer R.
Erdman, Paul
Tehrani, Lida
Robinson, Dale
Harris, Roy
Shevlin, Graziella
Perrin-Ninkovic, Sophie
Hilgraf, Robert
McCarrick, Margaret A.
Tam Tran
Fleming, Yuedi
Bai, April
Richardson, Samantha
Katz, Jason
Tang, Yang
Leisten, Jim
Moghaddam, Mehran
Cathers, Brian
Zhu, Dan
Sakata, Steven
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 747 - 752
[27] A New Chemotype of Chemically Tractable Nonsteroidal Estrogens Based on a Thieno[2,3-d]pyrimidine Core
Sammeta, Vamshikrishna Reddy
Norris, John D.
Artham, Sandeep
Torrice, Chad D.
Byemerwa, Jovita
Joiner, Carstyn
Fanning, Sean W.
McDonnell, Donald P.
Willson, Timothy M.
ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (07): : 1151 - 1158
[28] THIENO[2,3-D]PYRIMIDINES .1. NEW METHOD FOR PREPARATION OF ESTERS AND AMIDES OF THIENO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACIDS
SANTILLI, AA
KIM, DH
WANSER, SV
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1971, (MAR-A): : 91 - &
[29] PYRIDO[2,3-D]PYRIMIDINE AND PYRANO[2,3-D]PYRIMIDINE
CHUIGUK, VA
PINCHUK, NA
UKRAINSKII KHIMICHESKII ZHURNAL, 1982, 48 (10): : 1112 - 1113
[30] THIENO[2,3-D]PYRIMIDINES .1. NEW METHOD FOR PREPARATION OF ESTERS AND AMIDES OF THIENO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACIDS
SANTILLI, AA
KIM, DH
WANSER, SV
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1971, 8 (03) : 445 - &

← 1 2 3 4 5 →